CRGX vs. RGNX, HLVX, PRME, MESO, RLAY, KYTX, NVAX, PROK, EXAI, and IMTX
Should you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include REGENXBIO (RGNX), HilleVax (HLVX), Prime Medicine (PRME), Mesoblast (MESO), Relay Therapeutics (RLAY), Kyverna Therapeutics (KYTX), Novavax (NVAX), ProKidney (PROK), Exscientia (EXAI), and Immatics (IMTX). These companies are all part of the "biological products, except diagnostic" industry.
CARGO Therapeutics (NASDAQ:CRGX) and REGENXBIO (NASDAQ:RGNX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, community ranking, earnings and media sentiment.
In the previous week, REGENXBIO had 8 more articles in the media than CARGO Therapeutics. MarketBeat recorded 17 mentions for REGENXBIO and 9 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 0.50 beat REGENXBIO's score of 0.40 indicating that CARGO Therapeutics is being referred to more favorably in the media.
93.2% of CARGO Therapeutics shares are held by institutional investors. Comparatively, 88.1% of REGENXBIO shares are held by institutional investors. 1.4% of CARGO Therapeutics shares are held by insiders. Comparatively, 13.1% of REGENXBIO shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
CARGO Therapeutics has a net margin of 0.00% compared to REGENXBIO's net margin of -299.96%. CARGO Therapeutics' return on equity of 0.00% beat REGENXBIO's return on equity.
CARGO Therapeutics has higher earnings, but lower revenue than REGENXBIO.
CARGO Therapeutics currently has a consensus target price of $29.00, suggesting a potential upside of 42.02%. REGENXBIO has a consensus target price of $38.64, suggesting a potential upside of 141.63%. Given REGENXBIO's higher possible upside, analysts plainly believe REGENXBIO is more favorable than CARGO Therapeutics.
REGENXBIO received 418 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 65.84% of users gave REGENXBIO an outperform vote.
Summary
CARGO Therapeutics beats REGENXBIO on 8 of the 14 factors compared between the two stocks.
Get CARGO Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CRGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CARGO Therapeutics Competitors List
Related Companies and Tools
